Dexcom receives FDA warning letter for two U.S. manufacturing facilities [Yahoo! Finance Canada]
DexCom, Inc. (DXCM)
Last dexcom, inc. earnings: 4/28 04:03 pm
Check Earnings Report
US:NASDAQ Investor Relations:
dexcom.com/investors
Company Research
Source: Yahoo! Finance Canada
The company did not provide details about how many observations were made at the two sites, but said it does not "expect a material impact" from the letter to its manufacturing capacity or its sales guidance for fiscal year 2025. Dexcom said it had already submitted responses to the so-called "Form 483" and is in the process of preparing a written response. A Form 483 is a type of agency report containing "observations" that FDA inspectors "deem to be objectionable." Dexcom manufactures its products at its headquarters in San Diego, California and at its manufacturing facilities in Mesa, Arizona and Penang, Malaysia, according to a recent regulatory filing. It collectively operates about 80,600 square feet of laboratory space and about 159,600 square feet of controlled environment rooms across the three facilities. (Reporting by Arasu Kannagi Basil in Bengaluru; Editing by Arun Koyyur) Recommended Stories
Show less
Read more
Impact Snapshot
Event Time:
DXCM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DXCM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DXCM alerts
High impacting DexCom, Inc. news events
Weekly update
A roundup of the hottest topics
DXCM
News
- DEXCOM, INC. (NASDAQ: DXCM) DEADLINE ALERT Bernstein Liebhard LLP Reminds DexCom, Inc. Investors of Upcoming DeadlineGlobeNewswire
- DXCM CLASS ACTION ALERT: Kessler Topaz Meltzer & Check, LLP Reminds DexCom, Inc. Shareholders of Securities Fraud Class Action LawsuitPR Newswire
- Steelers' Jalen Ramsey shares honest feelings on 'Fire Tomlin' chants [USA TODAY]USA TODAY
- Jim Cramer on DexCom: “It's Too Rich a Stock” [Yahoo! Finance]Yahoo! Finance
- Myles Garrett sends message to Steelers' T.J. Watt after lung surgery [USA TODAY]USA TODAY
DXCM
Earnings
- 10/30/25 - Beat
DXCM
Sec Filings
- 11/17/25 - Form 4
- 11/14/25 - Form 144
- 11/12/25 - Form 4
- DXCM's page on the SEC website